|
|
H2014/CTD1380/187
|
APROVASC 150MG/10MG TABLET
|
IRBESARTAN / AMLODIPINE BESYLATE
|
RESSOURCETHICA KENYA LTD
|
Registered
|
Details →
|
|
|
H2014/CTD1381/188
|
APROVASC 150MG/5MG TABLET
|
IRBESARTAN / AMLODIPINE BESYLATE
|
RESSOURCETHICA KENYA LTD
|
Registered
|
Details →
|
|
|
H2014/CTD1383/190
|
APROVASC 300MG/10MG TABLET
|
IRBESARTAN / AMLODIPINE BESYLATE
|
RESSOURCETHICA KENYA LTD
|
Registered
|
Details →
|
|
|
H2014/CTD1382/189
|
APROVASC 300MG/5MG TABLET
|
IRBESARTAN / AMLODIPINE BESYLATE
|
RESSOURCETHICA KENYA LTD
|
Registered
|
Details →
|
|
|
H2020/CTD7097/13687
|
VAXIGRIP TETRA
|
A/MICHIGAN/45/2015 (H1N1)PDM09 - LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014,NYMC X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), B/PHUKET/3073/2013)-LIKE ST (B/PHU
|
RESSOURCETHICA KENYA LTD
|
Registered
|
Details →
|
|
|
3766
|
STAMARIL ATTENUATED YELLOW FEVER VACCINE
|
ATTENUATED YELLOW FEVER VIRUS 17 D STRAIN _>1000 U (CORRESPONDING TO LD50)
|
RESSOURCETHICA KENYA LTD
|
Registered
|
Details →
|
|
|
CTD 053/R1
|
Menactra (Meningococcal (Groups A C Y and W-135)…
|
Neisseria meningitidis serogroup A C Y and W-135…
|
Sanofi Pasteur S.A.
|
Retained
|
Details →
|
|
|
H2011/CTD053/356/R1
|
Menactra (Meningococcal (Groups A C Y and W-135)…
|
Neisseria meningitidis serogroup A C Y and W-135…
|
Sanofi Pasteur S.A.
|
Retained
|
Details →
|
|
|
H2008/20026/899
|
SHAN 5
|
DIPHTHERIA TOXOID,TETANUS TOXOID,WHOLE CELL PERTUSSIS,INACTIVATED POLIOMYELITIS VIRUS TYPE 1,2 AND 3,HAEMOPHILUS INFLUENZAE TYPE B CONJUGATED WITH TENANUS PROTEIN
|
RESSOURCETHICA KENYA LTD
|
Registered
|
Details →
|
|
|
H2026/CTD13175/26730
|
MENQUADFI
|
- N. MENINGITIDIS POLYSACCHARIDE TETANUS TOXOID CONJUGATE CONCENTRATE, SEROGROUP A - N. MENINGITIDIS POLYSACCHARIDE TETANUS TOXOID CONJUGATE CONCENTRATE, SEROGROUP C - N. MENINGITIDIS POLYSACCHARIDE TETANUS TOXOID CONJUGATE CONCENTRATE, SEROGROUP Y - N
|
RESSOURCETHICA KENYA LTD
|
Registered
|
Details →
|
|
|
18972
|
ARTESUNATE AMODIAQUINE WINTHROP 100MG/270MG TABLET
|
ARTESUNATE 100MG + AMODIAQUINE 270MG
|
RESSOURCETHICA KENYA LTD
|
Registered
|
Details →
|
|
|
18974
|
ARTESUNATE AMODIAQUINE WINTHROP 25MG/67.5MG TABLET
|
ARTESUNATE 25MG + AMODIAQUINE 67.5MG
|
RESSOURCETHICA KENYA LTD
|
Registered
|
Details →
|
|
|
18973
|
ARTESUNATE AMODIAQUINE WINTHROP 50MG/135MG TABLET
|
ARTESUNATE 50MG + AMODIAQUINE 135MG
|
RESSOURCETHICA KENYA LTD
|
Registered
|
Details →
|
|
|
CTD 455
|
ADACEL POLIO {DIPHTHERIA TETANUS PERTUSSIS ACELLULAR COMPONENT) AND POLIOMYELITIS (INACTIVATED VACCINE (ADSORBED REDUCED ANTIGENS)}
|
TETANUS TOXOID REDUCED DIPHTHERIA TOXOID ACELLULAR PERTUSSIS ANTIGENS [PERTUSSIS TOXOID (PT) FILAMENTOUS HAEMAGGLUTININ (FHA) PERTACTIN (PRN) FIMBRIAE TYPES 2 AND 3 (FIM)] AND INACTIVATED POLIOMYELITIS VACCINE [TYPE 1 (MAHONEY) TYPE 2 (MEF-1) AND
|
RESSOURCETHICA KENYA LTD
|
Registered
|
Details →
|
|
|
14630
|
APROVEL 150MG TABLET
|
IRBESARTAN
|
RESSOURCETHICA KENYA LTD
|
Registered
|
Details →
|
|
|
14631
|
APROVEL 300MG TABLET
|
IRBESARTAN
|
RESSOURCETHICA KENYA LTD
|
Registered
|
Details →
|
|
|
14630/R1
|
Aprovel 150mg tablet
|
Irbesartan
|
sanofi-aventis Kenya
|
Retained
|
Details →
|
|
|
16119
|
CO-APROVEL 150MG/12.5MG TABLET
|
IRBESARTAN 150MG + HYDROCHLOROTHIAZIDE 12.5MG
|
RESSOURCETHICA KENYA LTD
|
Registered
|
Details →
|
|
|
16120
|
CO-APROVEL 300MG/12.5MG TABLET
|
IRBESARTAN 300MG + HYDROCHLOROTHIAZIDE 12.5MG
|
RESSOURCETHICA KENYA LTD
|
Registered
|
Details →
|
|
|
21698
|
CO-APROVEL 300MG/25MG TABLET
|
IRBESARTAN 300MG + HYDROCHLOROTHIAZIDE 25MG
|
RESSOURCETHICA KENYA LTD
|
Registered
|
Details →
|